OTC Pharmaceuticals - France

  • France
  • Revenue in the OTC Pharmaceuticals market amounts to €4,083.00m in 2024. The market is expected to grow annually by 2.97% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of €1,358.00m in 2024.
  • In global comparison, most revenue is generated in the United States (€38,250m in 2024).
  • In relation to total population figures, per person revenues of €62.93 are generated in 2024.
  • In the OTC Pharmaceuticals market, 20.1% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Marché
 
Région
 
Comparaison de régions
 
Monnaie
 

Analyst Opinion

The OTC Pharmaceuticals market in France is experiencing steady growth due to changing customer preferences and market trends.

Customer preferences:
In recent years, there has been a shift in customer preferences towards self-medication and convenience. French consumers are increasingly seeking over-the-counter pharmaceutical products that can be easily purchased without a prescription. This trend is driven by the desire for quick and easy access to healthcare solutions, as well as the growing awareness and acceptance of self-care practices. Customers are also looking for products that offer a wide range of options and cater to specific health needs.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in France is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious about the ingredients and potential side effects of pharmaceutical products, leading them to seek natural alternatives. This trend is further fueled by the growing popularity of holistic and alternative medicine practices. As a result, there has been a surge in the availability of natural and herbal OTC products in the market. Another trend in the market is the growing emphasis on preventive healthcare. French consumers are increasingly proactive about their health and are willing to invest in OTC products that help prevent illnesses and maintain overall well-being. This trend is driven by the rising healthcare costs and the desire to reduce reliance on prescription medications. As a result, there has been an increase in the availability of OTC products that focus on preventive measures such as vitamins, supplements, and immune boosters.

Local special circumstances:
France has a well-established healthcare system that provides universal coverage and access to prescription medications. However, the high cost of prescription drugs and the long waiting times to see a doctor have led to an increased reliance on OTC pharmaceuticals. Additionally, the French government has implemented policies to promote self-medication and the use of OTC products, further driving the growth of the market.

Underlying macroeconomic factors:
The OTC Pharmaceuticals market in France is also influenced by macroeconomic factors such as population demographics and economic growth. The aging population in France is driving the demand for OTC products, as older individuals are more likely to require medication for chronic conditions and general health maintenance. Furthermore, the stable economic growth in France has resulted in increased disposable income, allowing consumers to spend more on healthcare products, including OTC pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in France is experiencing growth due to changing customer preferences towards self-medication and convenience. The market is characterized by an increasing demand for natural and herbal remedies, as well as a focus on preventive healthcare. The local special circumstances, including the well-established healthcare system and government policies, further contribute to the growth of the market. Additionally, underlying macroeconomic factors such as population demographics and economic growth play a significant role in shaping the market trends.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Vue d’ensemble

  • Revenue
  • Key Players
  • Analyst Opinion
  • Demographics
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter

Contact

Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Temitope Ifekoya
Temitope Ifekoya
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)